Clinical Trial Update: A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pembrolizumab in combination with trastuzumab and chemotherapy for patients with esophagogastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Adenocarcinoma

Drugs mentioned

• HERCEPTIN (trastuzumab)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Esophageal Cancer, Gastric Adenocarcinoma | Phase 2 | Status: RECRUITING